Scaling therapies for rare genetic diseases
A 2020 interview for Dave Lennon, former President of Novartis Gene Therapies. 
Please find the video below.
As part of the run-up to this year’s Reuters Events Cell & Gene USA conference (September 28-29, virtual), I’m so pleased to be able to share one of the incredible keynote interviews we conducted as part of last year’s event - I hope you find it of interest.
Register for Cell & Gene Therapy USA 2021 now. It’s free for employees of pharma, biotech and payer organizations >>>  
In this talk between Reuters Events’ Izzy Gladstone and Dave Lennon, President of Novartis Gene Therapies at the time of interview, they cover the ways that pharma and biotech can effectively scale their therapies for rare genetic diseases, and the challenges they will need to overcome along the way.

View the video in full below:
*having issues viewing the content? Click here
Cell & Gene Therapies USA 2021
September 28-29, Virtual (EST)
Including these incredible speakers, and more:
Register now for free >>>  
Register now for free >>>
I hope you enjoyed the interview - please let me know if you have any feedback, or if you want to get involved with the event.
Kind regards,
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.

Register now for Cell & Gene Therapy USA 2021

September 28-29, Virtual.

Challenge Area

Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy: https://www.thomsonreuters.com/en/privacy-statement.html.

Please note: As part of registering for a free pass to this virtual event, you are agreeing to potentially being introduced to relevant solution providers for prescheduled meetings on the virtual event platform in accordance with the challenges you have ticked above.